These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 2272356)

  • 1. Effect of ring fluorination of epinephrine on its cardiovascular adrenoceptor activities.
    Bass AS; Kohli JD; Adejare A; Kirk KL; Goldberg LI
    Eur J Pharmacol; 1990 Oct; 187(1):87-95. PubMed ID: 2272356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of ring fluorination on the cardiovascular actions of dopamine and norepinephrine in the dog.
    Goldberg LI; Kohli JD; Cantacuzene D; Kirk KL; Creveling CR
    J Pharmacol Exp Ther; 1980 Jun; 213(3):509-13. PubMed ID: 6894165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular activity of aromatic guanidine compounds.
    Hughes JL; Liu RC; Enkoji T
    J Med Chem; 1975 Nov; 18(11):1077-88. PubMed ID: 1177253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular responses to the stimulation of alpha-1 and alpha-2 adrenoceptors in the conscious dog.
    Woodman OL; Vatner SF
    J Pharmacol Exp Ther; 1986 Apr; 237(1):86-91. PubMed ID: 2870177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms mediating the positive inotropic and chronotropic changes induced by dopexamine in the anesthetized dog.
    Bass AS; Kohli JD; Lubbers N; Goldberg LI
    J Pharmacol Exp Ther; 1987 Sep; 242(3):940-4. PubMed ID: 2888876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoceptor blocking hemodynamic and coronary effects of YM-09538, a new combined alpha- and beta-adrenoceptor blocking drug, in anesthetized dogs.
    Takenaka T; Asano M; Berdeaux A; Giudicelli JF
    Eur J Pharmacol; 1982 Nov; 85(1):35-50. PubMed ID: 6129981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Catechol-substituted phenoxypropanolamines: adrenoceptor activity in the anaesthetized cat.
    Dowd H; Keh GS; Raper C
    Br J Pharmacol; 1977 Jun; 60(2):197-203. PubMed ID: 880431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological studies with the alpha 2-adrenoceptor antagonist midaglizole. Part I: Respiratory and cardiovascular systems.
    Hirohashi M; Takasuna K; Yamashita N; Tamura K
    Arzneimittelforschung; 1991 Jan; 41(1):9-18. PubMed ID: 1675573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats.
    Day MD; Roach AG
    Br J Pharmacol; 1974 Jul; 51(3):325-33. PubMed ID: 4451747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of epinephrine, norepinephrine, dopamine and their corresponding alpha-methyl-substituted derivatives with alpha and beta adrenoceptors in the pithed rat.
    Ruffolo RR; Goldberg MR; Morgan EL
    J Pharmacol Exp Ther; 1984 Sep; 230(3):595-600. PubMed ID: 6381693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular pharmacology of ASL-7022. III. Peripheral vascular adrenergic mechanisms.
    Gorczynski RJ; Reynolds RD
    J Pharmacol Exp Ther; 1985 Mar; 232(3):629-35. PubMed ID: 2857783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syntheses and adrenergic activities of ring-fluorinated epinephrines.
    Adejare A; Gusovsky F; Padgett W; Creveling CR; Daly JW; Kirk KL
    J Med Chem; 1988 Oct; 31(10):1972-7. PubMed ID: 2845082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of epinephrine and norepinephrine on cAMP response and g(i3)alpha protein expression in cultured sympathetic neurons.
    Shivachar AC; Eikenburg DC
    J Pharmacol Exp Ther; 1999 Oct; 291(1):258-64. PubMed ID: 10490912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cardiovascular effects of ICI 118,587: A beta 1-adrenoceptor partial agonist.
    Nuttall A; Snow HM
    Br J Pharmacol; 1982 Oct; 77(2):381-8. PubMed ID: 6128041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative inotropic effects of epinephrine in the presence of increased β-adrenoceptor sensitivity during hypothermia in a rat model.
    Dietrichs ES; Schanche T; Kondratiev T; Gaustad SE; Sager G; Tveita T
    Cryobiology; 2015 Feb; 70(1):9-16. PubMed ID: 25445571
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies of OPC-2009, a newly synthesized selective beta adrenoceptor stimulant, in the broncho-motor and cardiovascular system of the anesthetized dog.
    Yabuuchi Y; Yamashita S; Tei SS
    J Pharmacol Exp Ther; 1977 Aug; 202(2):326-36. PubMed ID: 18598
    [No Abstract]   [Full Text] [Related]  

  • 18. Downregulation of propranolol-sensitive beta-adrenoceptor signaling after inhibition of nitric oxide synthesis.
    Whalen EJ; Bates JN; Johnson AK; Lewis SJ
    Br J Pharmacol; 2006 Apr; 147(7):755-64. PubMed ID: 16474417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered adrenoceptor responsiveness during adrenaline infusion but not during mental stress: differences between receptor subtypes and tissues.
    Larsson PT; Martinsson A; Olsson G; Hjemdahl P
    Br J Clin Pharmacol; 1989 Dec; 28(6):663-74. PubMed ID: 2558700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular effects and interaction with adrenoceptors of urapidil.
    van Zwieten PA; de Jonge A; Wilffert B; Timmermans PB; Beckeringh JJ; Thoolen MJ
    Arch Int Pharmacodyn Ther; 1985 Aug; 276(2):180-201. PubMed ID: 4051641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.